Original language | English (US) |
---|---|
Pages (from-to) | 736 |
Number of pages | 1 |
Journal | Nature Reviews Drug Discovery |
Volume | 16 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2017 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
Access to Document
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Biometric monitoring devices for assessing end points in clinical trials : Developing an ecosystem. / Arneric, Stephen P.; Cedarbaum, Jesse M.; Khozin, Sean; Papapetropoulos, Spyros; Hill, Derek L.; Ropacki, Michael; Rhodes, Jane; Dacks, Penny A.; Hudson, Lynn D.; Gordon, Mark Forrest; Kern, Volker D.; Romero, Klaus; Vradenburg, George; Au, Rhoda; Karlin, Daniel R.; Facheris, Maurizio F.; Fitzer-Attas, Cheryl J.; Vitolo, Ottavio V.; Wang, Jian; Miller, Bradley M.; Kaye, Jeffrey A.
In: Nature Reviews Drug Discovery, Vol. 16, No. 10, 01.10.2017, p. 736.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Biometric monitoring devices for assessing end points in clinical trials
T2 - Developing an ecosystem
AU - Arneric, Stephen P.
AU - Cedarbaum, Jesse M.
AU - Khozin, Sean
AU - Papapetropoulos, Spyros
AU - Hill, Derek L.
AU - Ropacki, Michael
AU - Rhodes, Jane
AU - Dacks, Penny A.
AU - Hudson, Lynn D.
AU - Gordon, Mark Forrest
AU - Kern, Volker D.
AU - Romero, Klaus
AU - Vradenburg, George
AU - Au, Rhoda
AU - Karlin, Daniel R.
AU - Facheris, Maurizio F.
AU - Fitzer-Attas, Cheryl J.
AU - Vitolo, Ottavio V.
AU - Wang, Jian
AU - Miller, Bradley M.
AU - Kaye, Jeffrey A.
N1 - Funding Information: This work was supported, in part, by grant number 1U18FD005320 from the U.S. Food and Drug Administration’s Critical Path Public Private Partnerships Grant, and members including: AbbVie, Alzheimer’s Association, Alzheimer’s Disease Discovery Foundation (ADDF), Alzheimer’s Research UK, AstraZeneca, Biogen, Boehringer Ingelheim, CHDI Foundation, Lilly, Merck, Novartis, Pfizer, and UsAgainstAlzheimer’s.
PY - 2017/10/1
Y1 - 2017/10/1
UR - http://www.scopus.com/inward/record.url?scp=85032508559&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032508559&partnerID=8YFLogxK
U2 - 10.1038/nrd.2017.153
DO - 10.1038/nrd.2017.153
M3 - Letter
C2 - 28935908
AN - SCOPUS:85032508559
VL - 16
SP - 736
JO - Nature Reviews Drug Discovery
JF - Nature Reviews Drug Discovery
SN - 1474-1776
IS - 10
ER -